In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis' Partnership Ambitions

Executive Summary

Novartis' rather public search for a co-promotion partner for tegaserod (Zelmac) has ended up garnering the Swiss firm a bigger partner than it might have expected-and a partner that badly needed a drug to sell--Bristol-Myers. But Novartis is doing more with this co-promotion than simply finding a co-promtoion partner and some quids--it's advertising its willingness to go outside of the company's walls for the firepower it needs and its belief in the necessity of more global partnerships--or perhaps one really big one.
Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV001326

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel